About this trial
The goal of this study is to assess the performance of a commercial sheet sensor in determining body position after generalized tonic-clonic (GTC) seizures. If a sheet sensor could accurately detect GTC seizures, this could be a step towards autonomously repositioning patients with the aid of a smart mattress.
Primary Objective
Milestones:
Feasibility objective: Monitor 50 patients with the objective of capturing at least 20 GTCS events. Primary analytic objective: Achieve detection of anatomical landmarks with body position change within 5 seconds with an accuracy of 75% both interictally and post-GTCS.
Secondary Objective Detect the postictal prone position with an accuracy of 100%.
Eligibility criteria
Qualifiers
None
Disqualifiers
Suspicion of functional dissociative seizures (psychogenic nonepileptic seizures)
Patients admitted for medication adjustment only
Trial design
Treatments tested in this trial
- Study Subjects
Treatment groups
Sponsors and collaborators
Brigham and Women's Hospital
Lead sponsor
Soterya Inc.
Collaborator